Creo Medical Group (CREO) RNS Announcements

Add to Alert list
Date Time Source Announcement
16 Dec 2024 07:00 AM
RNS
Director/PDMR Shareholding
31 Oct 2024 04:36 PM
RNS
Total Voting Rights
24 Oct 2024 03:27 PM
RNS
Director/PDMR Shareholding (Replacement)
24 Oct 2024 02:33 PM
RNS
Director/PDMR Shareholding
21 Oct 2024 10:06 AM
RNS
Director/PDMR Share Dealings
18 Oct 2024 10:26 AM
RNS
Result of General Meeting & TVR
17 Oct 2024 05:29 PM
RNS
Result of Retail Offer
04 Oct 2024 07:00 AM
RNS
Extension of Retail Offer Closing Date
01 Oct 2024 07:00 AM
RNS
Result of Placing
30 Sep 2024 03:50 PM
RNS
Retail Offer for up to £5.0 million
30 Sep 2024 03:46 PM
RNS
Half-year Report
30 Sep 2024 03:45 PM
RNS
Proposed Placing, Launch of ABB, Retail Offer
18 Sep 2024 12:00 PM
RNS
Strategic Partnership & 51% subsidiary cash sale
29 Aug 2024 11:05 AM
RNS
Holding(s) in Company
01 Aug 2024 07:00 AM
RNS
Award of Shares under Share Incentive Plan
02 Jul 2024 07:00 AM
RNS
Creo and Intuitive amend collaboration agreement
26 Jun 2024 10:51 AM
RNS
Result of AGM
26 Jun 2024 07:00 AM
RNS
AGM Statement and Directorate Succession Planning
31 May 2024 07:00 AM
RNS
Posting of Annual Report and Accounts & AGM notice
15 May 2024 07:00 AM
RNS
Final Results
13 May 2024 07:00 AM
RNS
Directorate Changes
07 May 2024 07:00 AM
RNS
Creo Medical receives King’s Award for Enterprise
25 Apr 2024 07:00 AM
RNS
Notice of Results
24 Apr 2024 07:00 AM
RNS
NHS Speedboat data demonstrates savings
20 Mar 2024 04:52 PM
RNS
Holding(s) in Company
19 Mar 2024 07:00 AM
RNS
Welsh Labour Leader visits Creo’s facilities
13 Mar 2024 03:05 PM
RNS
Holding(s) in Company
13 Mar 2024 03:05 PM
RNS
Holding(s) in Company
11 Mar 2024 02:00 PM
RNS
LTIP Awards
06 Mar 2024 04:35 PM
RNS
Holding(s) in Company
01 Mar 2024 07:00 AM
RNS
Microwave Lung Ablation Update
07 Feb 2024 09:12 AM
RNS
Trading Update - Replacement
07 Feb 2024 07:00 AM
RNS
Trading Update
05 Feb 2024 07:00 AM
RNS
Strategic Collaboration with Khalifa University
31 Jan 2024 07:00 AM
RNS
Speedboat® UltraSlim roll-out reaches Asia Pacific
22 Jan 2024 07:00 AM
RNS
Award of Shares under Share Incentive Plan
10 Jan 2024 07:00 AM
RNS
First use of Speedboat® UltraSlim in Latin America
15 Dec 2023 07:00 AM
RNS
First use of Speedboat® UltraSlim in the USA
13 Dec 2023 07:00 AM
RNS
First European Speedboat® UltraSlim procedure
07 Nov 2023 07:00 AM
RNS
Capital Markets Day
01 Nov 2023 07:00 AM
RNS
Speedboat® UltraSlim: US FDA Clearance
25 Oct 2023 07:00 AM
RNS
SB UltraSlim: EU launch accelerated by 18 months
16 Oct 2023 10:16 AM
RNS
Change of Nominated Adviser and Joint Broker
12 Oct 2023 07:00 AM
RNS
Investor Presentation
12 Sep 2023 07:00 AM
RNS
Half-year Report
05 Sep 2023 07:00 AM
RNS
Notice of Results
16 Aug 2023 07:00 AM
RNS
Royal Oldham SSD service update
03 Aug 2023 07:00 AM
RNS
Half Year Trading Update
28 Jul 2023 07:00 AM
RNS
Total Voting Rights
24 Jul 2023 10:40 AM
RNS
Award of Shares under Share Incentive Plan

Creo Medical Group PLC is a medical device company that develops and sells minimally invasive electrosurgical devices for surgical endoscopy.

Creo Medical's technology includes the CROMA, which uses bipolar radiofrequency and high frequency microwave energy for cutting and coagulation. The company also has a proprietary energy technology called Kamaptive, which adapts to the tissue environment.

Creo Medical Group is listed on the London Stock Exchange under the ticker CREO.

CREO share price launched at 77p in 2016.

UK 100

Latest directors dealings